Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7297
    -0.0024 (-0.32%)
     

  • CRUDE OIL

    82.88
    +0.07 (+0.08%)
     

  • Bitcoin CAD

    87,936.95
    -3,119.48 (-3.43%)
     

  • CMC Crypto 200

    1,388.81
    -35.29 (-2.48%)
     

  • GOLD FUTURES

    2,330.20
    -8.20 (-0.35%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,471.00
    -193.50 (-1.10%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6818
    -0.0018 (-0.26%)
     

Why Amyris Stock Tumbled This Week

Eric Volkman, The Motley Fool
·2 min read
Why Amyris Stock Tumbled This Week

Amyris had a good news/bad news Tuesday, with the market deciding that the latter outweighed the former. The good was that three of the specialized biotech company's products will be included in the offerings of Sephora when the big cosmetics retailer launches its U.K. website. While having three out of the undoubtedly many Sephora products on the site isn't considerable and thus won't generate monster sales, being in that selection is indisputably a positive development for Amyris.

Continue reading